Literature DB >> 3718992

Optimal assay conditions for enzymatic characterization of homozygous and heterozygous twitcher mouse.

S Raghavan, A Krusell.   

Abstract

The neurological mouse mutant twitcher is characterized by a genetic deficiency of galactosylceramide beta-galactosidase (galcerase) (EC 3.2.1.46) which also represents lactosylceramide beta-galactosidase I (lactosidase I) activity. The assay conditions for both these activities in several mouse tissues have been optimized to facilitate the enzymatic characterization of homozygous and heterozygous twitcher mice. Galcerase in mouse tissues is optimally activated by 7.0 mg/ml of sodium taurocholate (pure) and 1.5-2.0 mg/ml of oleic acid in this system. When lactosylceramide is used as the substrate, no more than 1 mg/ml of taurocholate is appropriate in the assay, since higher concentrations of this pure bile salt stimulate another enzyme, lactosylceramide beta-galactosidase II (lactosidase II), which is unaffected in twitcher mice. At the optimized condition, lactosidase I in the twitcher mouse amounts to 3-4% of control activity in agreement with the residual galcerase (2%) in this mouse mutant. These assay conditions provide better sensitivity to discriminate heterozygotes from controls until 40 days of age from measurement of this activity in clipped tail samples.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3718992     DOI: 10.1016/0005-2760(86)90111-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Mesenchymal lineage stem cells have pronounced anti-inflammatory effects in the twitcher mouse model of Krabbe's disease.

Authors:  Cynthia B Ripoll; Mette Flaat; Jessica Klopf-Eiermann; Jeanne M Fisher-Perkins; Cynthia B Trygg; Brittni A Scruggs; Marjorie L McCants; Helen Paige Leonard; Amy F Lin; Shijia Zhang; Michelle E Eagle; Xavier Alvarez; Yu Teh Li; Su Chen Li; Jeffrey M Gimble; Bruce A Bunnell
Journal:  Stem Cells       Date:  2011-01       Impact factor: 6.277

2.  Galactocerebrosidase activity in somatic cell hybrids derived from twitcher mouse/control human fibroblasts is associated with human chromosome 17.

Authors:  T A Lyerla; J T Konola; M C Skiba; S Raghavan
Journal:  Am J Hum Genet       Date:  1989-02       Impact factor: 11.025

3.  Globoid cell leukodystrophy (Krabbe disease) in a Merino sheep.

Authors:  Effie Lee; Maria Fuller; Mandi Carr; Jim Manavis; John Finnie
Journal:  J Vet Diagn Invest       Date:  2018-10-17       Impact factor: 1.279

4.  Multipotent stromal cells alleviate inflammation, neuropathology, and symptoms associated with globoid cell leukodystrophy in the twitcher mouse.

Authors:  Brittni A Scruggs; Xiujuan Zhang; Annie C Bowles; Peter A Gold; Julie A Semon; Jeanne M Fisher-Perkins; Shijia Zhang; Ryan W Bonvillain; Leann Myers; Su Chen Li; Allan V Kalueff; Bruce A Bunnell
Journal:  Stem Cells       Date:  2013-08       Impact factor: 6.277

5.  Glucocerebrosidases catalyze a transgalactosylation reaction that yields a newly-identified brain sterol metabolite, galactosylated cholesterol.

Authors:  Hisako Akiyama; Mitsuko Ide; Yasuko Nagatsuka; Tomoko Sayano; Etsuro Nakanishi; Norihito Uemura; Kohei Yuyama; Yoshiki Yamaguchi; Hiroyuki Kamiguchi; Ryosuke Takahashi; Johannes M F G Aerts; Peter Greimel; Yoshio Hirabayashi
Journal:  J Biol Chem       Date:  2020-03-06       Impact factor: 5.157

6.  Establishment of a galactocerebrosidase-deficient twitcher mouse cell line that expresses galactocerebrosidase activity in hybrids with control human fibroblasts.

Authors:  J T Konola; T A Lyerla; M C Skiba; S Raghavan
Journal:  In Vitro Cell Dev Biol       Date:  1988-06

7.  Transplantation of mouse embryonic stem cell-derived oligodendrocytes in the murine model of globoid cell leukodystrophy.

Authors:  Xiao Ling Kuai; Run Zhou Ni; Guo Xiong Zhou; Zheng Biao Mao; Jian Feng Zhang; Nan Yi; Zhao Xiu Liu; Nan Shao; Wen Kai Ni; Zhi Wei Wang
Journal:  Stem Cell Res Ther       Date:  2015-03-14       Impact factor: 6.832

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.